We read with interest the recent article by Moody et al. [
[1]
] regarding the morbidity of lymph node dissection for melanoma, comparing therapeutic
dissection (TLND) in the setting of clinically apparent disease to completion dissection
after sentinel node biopsy (CLND). The authors concluded that although there is a
marginally lower rate of surgical complications for CLND, “it is not to a level of
statistical significance.”To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Surgical OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma – a systematic review of the literature.Eur J Surg Oncol. 2017; 43: 1760-1767
- Complications associated with sentinel lymph node biopsy for melanoma.Ann Surg Oncol. 2003; 10: 676-680
- Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.Lancet Oncol. 2016; 17: 757-767
- The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).Ann Surg Oncol. 2010; 17: 3324-3329
Article info
Publication history
Published online: October 26, 2017
Accepted:
September 17,
2017
Received:
September 14,
2017
Identification
Copyright
© 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
